Close Menu

NEW YORK (GenomeWeb) – Fulgent Genetics reported on Monday that its second quarter revenues rose 17 percent as it integrated its newly reorganized sales force.

For the three months ended June 30, Fulgent's revenues climbed to $4.6 million from $4.0 million the year before.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.